Elekta (EKTAY)
(Delayed Data from OTC)
$6.71 USD
+0.08 (1.21%)
Updated Oct 18, 2024 03:59 PM ET
2-Buy of 5 2
A Value F Growth B Momentum B VGM
Price, Consensus and EPS Surprise
EKTAY 6.71 +0.08(1.21%)
Will EKTAY be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for EKTAY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EKTAY
Is Elekta (EKTAY) Stock Undervalued Right Now?
Should Value Investors Buy Avanos Medical (AVNS) Stock?
EKTAY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Elekta (EKTAY) a Great Value Stock Right Now?
Should Value Investors Buy Elekta (EKTAY) Stock?
Are Investors Undervaluing Elekta (EKTAY) Right Now?
Other News for EKTAY
Elekta price target raised by SEK 4 at JPMorgan
Elekta AB (publ) (EKTAF) Q1 2025 Earnings Call Transcript
Accuray Remains A Perpetual 'Next Year Is Our Year' Story